229 related articles for article (PubMed ID: 11087777)
1. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Schifter S; Jansen-Olesen I; Olesen J
Neurology; 2000 Nov; 55(9):1335-40. PubMed ID: 11087777
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide in cervicogenic headache.
Frese A; Schilgen M; Edvinsson L; Frandsen E; Evers S
Cephalalgia; 2005 Sep; 25(9):700-3. PubMed ID: 16109051
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide in tension-type headache.
Ashina M
ScientificWorldJournal; 2002 Jun; 2():1527-31. PubMed ID: 12806133
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Ekman R; Olesen J
Pain; 1999 Dec; 83(3):541-547. PubMed ID: 10568863
[TBL] [Abstract][Full Text] [Related]
5. Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period.
Gupta R; Ahmed T; Banerjee B; Bhatia M
J Headache Pain; 2009 Jun; 10(3):161-6. PubMed ID: 19277835
[TBL] [Abstract][Full Text] [Related]
6. No increase of calcitonin gene-related peptide in jugular blood during migraine.
Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
[TBL] [Abstract][Full Text] [Related]
7. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
8. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
10. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide levels during nitric oxide-induced headache in patients with chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
Eur J Neurol; 2001 Mar; 8(2):173-8. PubMed ID: 11284996
[TBL] [Abstract][Full Text] [Related]
12. Low plasma levels of calcitonin gene-related peptide in persistent post-traumatic headache attributed to mild traumatic brain injury.
Ashina H; Al-Khazali HM; Iljazi A; Ashina S; Jørgensen NR; Amin FM; Ashina M; Schytz HW
Cephalalgia; 2020 Oct; 40(12):1276-1282. PubMed ID: 32689824
[TBL] [Abstract][Full Text] [Related]
13. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
14. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.
Tfelt-Hansen P; Le H
J Headache Pain; 2009 Jun; 10(3):137-43. PubMed ID: 19330286
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
17. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
18. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
19. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release.
Juhasz G; Zsombok T; Modos EA; Olajos S; Jakab B; Nemeth J; Szolcsanyi J; Vitrai J; Bagdy G
Pain; 2003 Dec; 106(3):461-470. PubMed ID: 14659530
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin-gene related peptide and disease activity in cluster headache.
Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
